Skip to content

The survey of the effect of aromatherapy on patients undergoing chemotherapy

The survey of the effect of aromatherapy with Rosa damascena essence on chemotherapy-induced nausea and vomiting: a randomized clinical trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20121208011692N4
Enrollment
62
Registered
2025-02-18
Start date
2025-02-19
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer. Elevated cancer antigen 125 [CA 125]

Interventions

Intervention group: In the intervention group, aromatherapy with Rosa damascena essence will be performed alongside routine treatments. The intervention will be carried out from the day of chemotherap

Sponsors

Yasouj University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Definite diagnosis of cancer by an oncologist Completed at least one course of chemotherapy with antiemetic chemotherapy drugs including cyclophosphamide, cisplatin, carboplatin and doxorubicin in a single or multiple regimen No history of nausea and vomiting for reasons other than chemotherapy No digestive problems or diarrhea Age over 18 Not pregnant or breastfeeding Not taking sedatives and antidepressants

Exclusion criteria

Exclusion criteria: Lack of study inclusion criteria Unwillingness to participate in the study

Design outcomes

Primary

MeasureTime frame
Chemotherapy-induced nausea and vomiting score on the MAT questionnaire. Timepoint: In 3 cycles of chemotherapy, 2 times per cycle (in the first 24 hours and after the first 24 hours after chemotherapy). Method of measurement: Multinational Association of Supportive Care in Cancer Antiemesis Tool.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAfrasiabifar Ardashir

Yasouj University of Medical Sciences

afrasiabifar.ardashir@yums.ac.ir+98 74 3323 4115

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026